为最佳的动态处理方案同时进行特征选择.
Mochuan Liu1, Yuanjia Wang2, Donglin Zeng3
1Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
本研究介绍了动态治疗方案 (DTR) 的L1多阶段坡道损失 (L1-MRL) 学习. 该方法同时优化治疗决策,并在所有阶段选择相关特征,改进精准医学应用.
科学领域:
- 生物统计学 生物统计学
- 机器学习 机器学习
- 精准医学是一门精准的医学.
背景情况:
- 动态治疗方案 (DTRs) 对于个性化医疗至关重要,随着时间的推移,根据患者的特征量身定制治疗.
- 当前的DTR方法经常使用顺序方法,导致跨阶段的特征选择中累积错误.
- 有效的特征选择对于开发节可靠的DTR至关重要.
研究的目的:
- 为所有阶段同时优化DTR和特征选择开发一种新的框架.
- 为了解决现有的顺序方法在处理多个决策点的功能重要性方面的局限性.
- 为了提高学习最佳DTR的可靠性和实用性,在精准医学中.
主要方法:
- 拟议的L1多阶段坡道损失 (L1-MRL) 学习框架,用于同时优化DTR和变量选择.
- 利用单一的多阶段坡道损失函数来估计所有阶段的最佳DTR.
- 实施了群体拉索类惩罚,用于识别任何阶段重要的特征.
主要成果:
- 从理论上证明了拟议的L1-MRL估计器的一致性和预言性.
- 模拟研究表明,L1-MRL的性能与现有的DTR方法相比或更好,具有变量选择.
- 将该方法应用于2型糖尿病 (T2D) 患者的电子健康记录 (EHR) 数据.
结论:
- L1-MRL学习提供了一种强大的方法,用于开发有效的DTR,同时进行特征选择.
- 该方法克服了顺序方法的局限性,减少了虚假发现错误.
- 这一框架通过使更可靠和节的治疗策略成为可能,推进了精准医学.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
03:37Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis of Population Pharmacokinetic Data
Comparing the Survival Analysis of Two or More Groups
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
